OTCM
ACAI
Market cap7kUSD
Oct 08, Last price
0.00USD
1Q
837.50%
Jan 2017
-50.00%
IPO
-100.00%
Name
Safeplus International Holdings Ltd
Chart & performance
P/E
—
P/S
—
EPS
—
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
-10.08%
Revenues
0
Net income
-19k
L-69.69%
CFO
0
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Safeplus International Holdings Limited, headquartered in Pittsford, New York, and established in 1963, specializes in developing and bringing to market advanced technological solutions for the medical device sector. Formerly operating as Biophan Technologies, Inc. until its rebranding in September 2020, the company is currently looking for partners to help commercialize its extensive portfolio of patented innovations. These proprietary technologies include biothermal power supplies, pulsewidth modulation designed to significantly improve the functionality of pacemakers and neurostimulators, and patented breakthroughs in photonics and nanomaterials.
Key people
Chairman of the Board · since 2008
John Lanzafame
Chief Executive Officer, Director · since 2008
Margaret Russell
Chief Financial Officer, Treasurer, Secretary · since 2008
Director · since 2006
Harold Gubnitsky
Director · since 2008
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2022‑02 | 2021‑02 | 2020‑02 | 2019‑02 | 2018‑02 | |
| Income | |||||
Revenues | |||||
Cost of revenue | |||||
Unusual Expense (Income) | |||||
NOPBT | |||||
NOPBT Margin | |||||
Operating Taxes | |||||
Tax Rate | |||||
NOPAT | |||||
Net income | |||||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | |||||
BB yield | |||||
| Debt | |||||
Debt current | |||||
Long-term debt | |||||
Deferred revenue | |||||
Other long-term liabilities | |||||
Net debt | |||||
| Cash flow | |||||
Cash from operating activities | |||||
CAPEX | |||||
Cash from investing activities | |||||
Cash from financing activities | |||||
FCF | |||||
| Balance | |||||
Cash | |||||
Long term investments | |||||
Excess cash | |||||
Stockholders' equity | |||||
Invested Capital | |||||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | |||||
Price | |||||
Market cap | |||||
EV | |||||
EBITDA | |||||
EV/EBITDA | |||||
Interest | |||||
Interest/NOPBT | |||||